GENEVA, Oct. 22 -- ADVANCED CENTRE FOR TREATMENT, RESEARCH & EDUCATION IN CANCER, (ACTREC) filed a patent application (IN2025/051444) for “IMMUNE MODULATING THERAPY USING UC-MSC-CM TO INHIBIT TUMOR GROWTH”. With publication no. WO/2026/069350, here are the other details related to the patent application:
Kind: Later publication of international search report [A3]
IPC: A61K 35/51
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....